Literature DB >> 33413556

Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus.

Jinjin Shi1, Chu Chu1, Min Yu1, Dandan Zhang1, Yuqin Li1, Yujie Fan1, Yixue Yu1, Yali Luo1, Weifang Zhou2.   

Abstract

OBJECTIVES: This study aimed to compare the clinical features and laboratory tests of infectious mononucleosis (IM) and hemophagocytic syndrome (HLH) caused by Epstein-Barr virus (EBV) in 1-3-year-old children and to explore the risk factor of HLH caused by EBV (EBV-HLH).
METHODS: The clinical data of 92 children with EBV infection admitted in our hospital from 2011 to 2019 were collected; 61 cases were diagnosed as EBV-IM, and 31 cases were diagnosed as EBV-HLH. The subjects' clinical manifestations and laboratory tests were analyzed retrospectively.
RESULTS: Compared with EBV-IM patients, EBV-HLH patients had longer durations of fever, both before hospitalization and overall, and a higher probability of hepatomegaly. The levels of ALT, AST, LDH, TG, SF, D-Dimer and the plasma EBV DNA load of EBV-HLH patients were significantly higher than those of EBV-IM patients. The absolute values of CD3+, CD4+, CD8+, NK, and CD3-CD19+ cells and IgA and IgM levels of EBV-HLH patients were significantly lower than those of EBV-IM patients. The plasma EBV DNA load was positively correlated with the PT, TT, α-HBDH, AST, LDH, CK, Scr, BUN, UA, TG, and CRP levels in EBV-HLH patients, and the plasma EBV DNA load was positively correlated with the D-Dimer level in the EBV-IM patients. Among the 10 different potential markers, at the cut-off point of 1721.500 μg/L, the sensitivity and specificity of D-Dimer was 88.90 and 90.20%, respectively.
CONCLUSION: The D-Dimer level may be a good prognostic indicator of EBV-HLH caused by EBV.

Entities:  

Keywords:  D-dimer; EBV DNA load; Hemophagocytic syndrome; Infectious mononucleosis

Mesh:

Year:  2021        PMID: 33413556      PMCID: PMC7788532          DOI: 10.1186/s13052-020-00949-7

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN: 1720-8424            Impact factor:   2.638


  15 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

Review 2.  Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review.

Authors:  Roger Chou; Daniel Hartung; Basmah Rahman; Ngoc Wasson; Erika Barth Cottrell; Rongwei Fu
Journal:  Ann Intern Med       Date:  2013-01-15       Impact factor: 25.391

3.  Haemophagocytic lymphohistiocytosis as a consequence of untreated B-cell chronic lymphocytic leukaemia.

Authors:  Chris Bailey; Claire Dearden; Kirit Ardeshna
Journal:  BMJ Case Rep       Date:  2017-04-26

4.  [Principle suggestions for diagnosis and treatment of main nontumorous Epstein-Barr virus-associated diseases in children].

Authors: 
Journal:  Zhonghua Er Ke Za Zhi       Date:  2016-08

5.  D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.

Authors:  John Simes; Kristy P Robledo; Harvey D White; David Espinoza; Ralph A Stewart; David R Sullivan; Tanja Zeller; Wendy Hague; Paul J Nestel; Paul P Glasziou; Anthony C Keech; John Elliott; Stefan Blankenberg; Andrew M Tonkin
Journal:  Circulation       Date:  2018-08-14       Impact factor: 29.690

6.  Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.

Authors:  Carrie B Coleman; Eric M Wohlford; Nicholas A Smith; Christine A King; Julie A Ritchie; Paul C Baresel; Hiroshi Kimura; Rosemary Rochford
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

7.  D-dimer is a significant prognostic factor in patients with suspected infection and sepsis.

Authors:  Joaquín R Rodelo; Gisela De la Rosa; Martha L Valencia; Sigifredo Ospina; Clara M Arango; Carlos I Gómez; Alex García; Edilberto Nuñez; Fabián A Jaimes
Journal:  Am J Emerg Med       Date:  2012-07-15       Impact factor: 2.469

Review 8.  Ebola Virus Disease has Features of Hemophagocytic Lymphohistiocytosis Syndrome.

Authors:  Andre J A M van der Ven; Mihai G Netea; Jos W M van der Meer; Quirijn de Mast
Journal:  Front Med (Lausanne)       Date:  2015-02-04

9.  Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants.

Authors:  Masataka Ishimura; Katsuhide Eguchi; Akira Shiraishi; Motoshi Sonoda; Yoshihiro Azuma; Hiroyuki Yamamoto; Ken-Ichi Imadome; Shouichi Ohga
Journal:  Front Pediatr       Date:  2019-05-21       Impact factor: 3.418

10.  [Natural killer cell cytotoxic activity in critical pediatric patients with suspected hemophagocytic syndrome].

Authors:  I Martínez; L Fernández; J Valentín; C Castillo; C Chamorro; A Pérez-Martínez
Journal:  Med Intensiva       Date:  2014-07-28       Impact factor: 2.491

View more
  2 in total

1.  HLA-DR Expression Level in CD8+ T Cells Correlates With the Severity of Children With Acute Infectious Mononucleosis.

Authors:  Yun Wang; Ying Luo; Guoxing Tang; Renren Ouyang; Minxia Zhang; Yuhuan Jiang; Ting Wang; Xiwen Zhang; Botao Yin; Jin Huang; Wei Wei; Min Huang; Feng Wang; Shiji Wu; Hongyan Hou
Journal:  Front Immunol       Date:  2021-11-03       Impact factor: 7.561

2.  Analysis of Prognostic Risk Factors and Establishment of Prognostic Scoring System for Secondary Adult Hemophagocytic Syndrome.

Authors:  Qiaolei Zhang; Youyan Lin; Yejiang Bao; Yuan Jin; Xiujin Ye; Yamin Tan
Journal:  Curr Oncol       Date:  2022-02-15       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.